Welcome to

MST Financial

A research driven financial services platform.

MST has an absolute focus on value creation for our clients. MST's innovative platform enables the best talent in financial services to collaborate with clients in an exclusive partnership.

MST platform offers institutional research through its Marquee platform and issuer sponsored equity research through its Access platform.

Institutional Large Cap Research

Mid-Large Cap and Emerging Research

Issuer Sponsored. Open Access to Investors

Capital Markets

Corporate Advisory

Income Solutions

MST Financial 4th Sydney Director & Executive Forum

Nov 01, 2024

We are delighted with the success of our fourth Sydney Director & Executive Forum, held in collaboration with MinterEllison last night.

ASX earnings outlook trimmed on rising costs for industrials and revenue weakness for resources

Aug 26, 2024

MST Financial Senior Strategy Analyst, Hasan Tevfik is quoted in The Australian sharing his insights on corporate earnings season.

MST Financial hosts Making Sense of Markets Webinar

Aug 08, 2024

MST Financial hosted a Making Sense of Markets Webinar where Sandstone Strategist John Lockton, and Sales Executive Jarrod Bakker provided a comprehensive analysis of the recent drivers of market volatility.

MST Financial Perth Director & Executive Forum

Aug 02, 2024

We are delighted with the success of our second Perth Director & Executive Forum, held in collaboration with Ashurst last night.

MST Financial Hosts Emerging Financials Forum

Jul 15, 2024

MST Financial is thrilled to be hosting the Emerging Financials Forum Webinar on Wednesday, 24 July 2024 from 11.00am. Managing Directors of Kina Bank and Auswide Bank will be presenting, showcasing two of the emerging small-cap banks in the Australian Financial Services sector.

MST Financial Sole Lead Manager in A$227M Raise for Opthea Limited (OPT.ASX)

Jun 20, 2024

MST Financial is proud to have supported Opthea Ltd (OPT.ASX) acting as Sole Lead Manager to the company’s A$227 million capital raising – the largest pre-Phase 3 readout biotech raise ever in Australia (ex CSL).